John Craig Venter is an American biotechnologist and businessman. He is known for leading one of the first draft sequences of the human genome and assembled the first team to transfect a cell with a synthetic chromosome. Wikipedia
Born: 1946 (age 77 years), Salt Lake City, UT
Education: University of California San Diego (1972), College of San Mateo, and Mills High School
Spouse: Heather Kowalski (m. 2008) and Claire M. Fraser (m. 1981–2005)
Organizations founded: The Institute for Genomic Research, Celera Corporation, Human Longevity, and more
Parents: John Venter and Elizabeth Venter
People also ask
What did Craig Venter discover?
What happened to Craig Venter?
What is the net worth of Venter?
How did Craig Venter make his money?
He was the co-founder of Human Longevity Inc. and Synthetic Genomics. He was listed on Time magazine's 2007 and 2008 Time 100 list of the most influential ...
J. Craig Venter, PhD, is regarded as one of the leading scientists of the 21st century for his numerous invaluable contributions to genomic research.
JCVI is advancing the science of genomics through bold innovations. Our mission is to understand more about the biological world, and to develop unique insights ...
Craig Venter, the man who led the private effort to sequence the human genome, is hard at work now on even more potentially world-changing projects.
A leading scientist of the 21st century for Genomic Sciences; Co-Founder, Chairman, Synthetic Genomics, Inc.; Founder, J. Craig Venter Institute; Author, ...
J. Craig Venter is regarded as one of the leading scientists of the 21st century for his invaluable contributions to genomic research.
Apr 9, 2024 · J. Craig Venter is an American geneticist, biochemist, and businessman who pioneered new techniques in genetics and genomics research and ...
Feb 21, 2017 · Craig Venter, the man who mapped the human genome, is back with a $25000 physical he hopes can extend your life--and make him a billionaire.
J. Craig Venter made waves in 1998 when he and his for-profit company, Celera, challenged the public Human Genome Project to a DNA-sequencing race.